Published : Dec-2019
No. of Pages : 188
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Tissue Sealants Overview 9
3 Products under Development 10
3.1 Tissue Sealants - Pipeline Products by Stage of Development 10
3.2 Tissue Sealants - Pipeline Products by Segment 11
3.3 Tissue Sealants - Pipeline Products by Territory 12
3.4 Tissue Sealants - Pipeline Products by Regulatory Path 13
3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date 14
3.6 Tissue Sealants - Ongoing Clinical Trials 15
4 Tissue Sealants - Pipeline Products under Development by Companies 16
4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development 16
4.2 Tissue Sealants - Pipeline Products by Stage of Development 18
5 Tissue Sealants Companies and Product Overview 20
5.1 Adhesys Medical GmbH Company Overview 20
5.2 Advanced Medical Solutions Group plc Company Overview 22
5.3 Aleo BME Inc Company Overview 23
5.4 Angiotech Pharmaceuticals Inc Company Overview 24
5.5 Arch Therapeutics Inc Company Overview 25
5.6 Arizona State University Company Overview 26
5.7 Baxter International Inc Company Overview 27
5.8 Biomedica Management Corp Company Overview 28
5.9 Boston University Company Overview 29
5.10 C. R. Bard Inc Company Overview 30
5.11 Calmare Therapeutics Inc Company Overview 32
5.12 Clemson University Company Overview 33
5.13 Cohera Medical Inc Company Overview 34
5.14 Covalent Medical, Inc. (Inactive) Company Overview 37
5.15 DSM Biomedical BV Company Overview 38
5.16 Elastagen Pty Ltd Company Overview 39
5.17 Ethicon Endo-Surgery Inc Company Overview 40
5.18 Gamma Therapeutics Inc Company Overview 41
5.19 GATT Technologies BV Company Overview 42
5.20 Grifols SA Company Overview 44
5.21 Grifols USA LLC Company Overview 45
5.22 Hemostasis LLC Company Overview 46
5.23 HyperBranch Medical Technology Inc Company Overview 50
5.24 Institute of Molecular Biology of Parana Company Overview 52
5.25 InVivo Therapeutics Corp Company Overview 53
5.26 Johns Hopkins University Company Overview 54
5.27 Kollodis BioSciences Inc Company Overview 55
5.28 Kuros Biosciences AG Company Overview 56
5.29 Laser Tissue Welding, Inc. Company Overview 58
5.30 LifeBond Ltd Company Overview 61
5.31 Medisse BV (Inactive) Company Overview 65
5.32 Pharming Group NV Company Overview 66
5.33 Polyganics BV Company Overview 67
5.34 Protein Polymer Technologies Inc (Inactive) Company Overview 73
5.35 Purdue University Company Overview 74
5.36 Samyang Biopharmaceuticals Corp Company Overview 75
5.37 Sealantis Ltd. Company Overview 76
5.38 Shanghai Haohai Biological Technology Co Ltd Company Overview 80
5.39 Surgical Sealants, Inc. Company Overview 82
5.40 Teijin Pharma Ltd Company Overview 83
5.41 Texas A&M University Company Overview 84
5.42 The Medicines Company Company Overview 86
5.43 Tissium SA Company Overview 87
5.44 University of Akron Company Overview 88
6 Tissue Sealants- Recent Developments 89
6.1 Nov 19, 2019: ThermoGenesis Holdings announces improved third quarter 2019 financial results and provides corporate update 89
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 91
6.3 Oct 31, 2019: Cesca Therapeutics to change name and ticker symbol to reflect new strategic focus 93
6.4 Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran 94
6.5 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 95
6.6 Oct 28, 2019: PolyNovo: Appointment non-executive director - Dr Robyn Elliott 96
6.7 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 96
6.8 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 98
6.9 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 99
6.10 Oct 08, 2019: Samyang Biopharm USA expands and strengthens its US operations and makes additions to executive team in key business areas 100
7 Appendix 184
7.1 Methodology 184
7.2 About GlobalData 187
7.3 Contact Us 187
7.4 Disclaimer 187
List of Tables
Table 1: Tissue Sealants - Pipeline Products by Stage of Development 11
Table 2: Tissue Sealants - Pipeline Products by Segment 12
Table 3: Tissue Sealants - Pipeline Products by Territory 13
Table 4: Tissue Sealants - Pipeline Products by Regulatory Path 14
Table 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 15
Table 6: Tissue Sealants - Ongoing Clinical Trials 16
Table 7: Tissue Sealants Companies - Pipeline Products by Stage of Development 17
Table 8: Tissue Sealants - Pipeline Products by Stage of Development 19
Table 9: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
Table 10: CUTIS - Product Status 21
Table 11: CUTIS - Product Description 21
Table 12: VIVO - Product Status 22
Table 13: VIVO - Product Description 22
Table 14: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 15: Next Generation Internal Fixation And Sealant Device - Product Status 23
Table 16: Next Generation Internal Fixation And Sealant Device - Product Description 23
Table 17: Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 18: Dural Sealant - Product Status 24
Table 19: Dural Sealant - Product Description 24
Table 20: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 21: Hemaseel HMN Fibrin Sealant - Product Status 25
Table 22: Hemaseel HMN Fibrin Sealant - Product Description 25
Table 23: Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 24: AC5 Surgery - Sealant - Product Status 26
Table 25: AC5 Surgery - Sealant - Product Description 26
Table 26: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 27
Table 27: Laser-Activated Nanosealant - Product Status 27
Table 28: Laser-Activated Nanosealant - Product Description 27
Table 29: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 30: Tisseel Dura - Product Status 28
Table 31: Tisseel Dura - Product Description 28
Table 32: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 33: ClotBlock - Product Status 29
Table 34: ClotBlock - Product Description 29
Table 35: Boston University Pipeline Products & Ongoing Clinical Trials Overview 30
Table 36: Hydrogel-Based Aerosolized Sealant Dressing - Product Status 30
Table 37: Hydrogel-Based Aerosolized Sealant Dressing - Product Description 30
Table 38: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 39: Progel Dural Sealant - Product Status 31
Table 40: Progel Dural Sealant - Product Description 31
Table 41: Progel Emerald - Product Status 32
Table 42: Progel Emerald - Product Description 32
Table 43: Tridyne Peripheral - Product Status 32
Table 44: Tridyne Peripheral - Product Description 32
Table 45: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: Wound Sealant - Product Status 33
Table 47: Wound Sealant - Product Description 33
Table 48: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 34
Table 49: Surgical Adhesive Hydrogel - Product Status 34
Table 50: Surgical Adhesive Hydrogel - Product Description 34
Table 51: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 52: Sylys Surgical Sealant - Product Status 35
Table 53: Sylys Surgical Sealant - Product Description 35
Table 54: Sylys Surgical Sealant - Drug Delivery - Product Status 36
Table 55: Sylys Surgical Sealant - Drug Delivery - Product Description 36
Table 56: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status 36
Table 57: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description 37
Table 58: Sylys Surgical Sealant - Orthopedic Procedures - Product Status 37
Table 59: Sylys Surgical Sealant - Orthopedic Procedures - Product Description 37
Table 60: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
List of Figures
Figure 1: Tissue Sealants - Pipeline Products by Stage of Development 11
Figure 2: Tissue Sealants - Pipeline Products by Segment 12
Figure 3: Tissue Sealants - Pipeline Products by Territory 13
Figure 4: Tissue Sealants - Pipeline Products by Regulatory Path 14
Figure 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 15
Figure 6: Tissue Sealants - Ongoing Clinical Trials 16
